DUSP9 and hepatocellular carcinoma: Normalized against adjacent non‐tumour tissues (mean expression = 1), DUSP9 was upregulated in 52.1% of 2048 HCC tumours, whereas only 5.8% of tumours showed downregulation (Figure 3F).